Related references
Note: Only part of the references are listed.Frontal Glutamate and γ-Aminobutyric Acid Levels and Their Associations With Mismatch Negativity and Digit Sequencing Task Performance in Schizophrenia
Laura M. Rowland et al.
JAMA PSYCHIATRY (2016)
The Paradoxical Relationship between White Matter, Psychopathology and Cognition in Schizophrenia: A Diffusion Tensor and Proton Spectroscopic Imaging Study
Arvind Caprihan et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Magnetic resonance spectroscopy and tissue protein concentrations together suggest lower glutamate signaling in dentate gyrus in schizophrenia
A. D. Stan et al.
MOLECULAR PSYCHIATRY (2015)
Biological insights from 108 schizophrenia-associated genetic loci
Stephan Ripke et al.
NATURE (2014)
A Guide to the Metabolic Pathways and Function of Metabolites Observed in Human Brain H-1 Magnetic Resonance Spectra
Caroline D. Rae
NEUROCHEMICAL RESEARCH (2014)
Reduced Frontal Glutamate plus Glutamine and N-Acetylaspartate Levels in Patients With Chronic Schizophrenia but not in Those at Clinical High Risk for Psychosis or With First-Episode Schizophrenia
Tatsunobu Natsubori et al.
SCHIZOPHRENIA BULLETIN (2014)
Increased Glutamine in Patients Undergoing Long-term Treatment for Schizophrenia A Proton Magnetic Resonance Spectroscopy Study at 3 T
Juan R. Bustillo et al.
JAMA PSYCHIATRY (2014)
Multimodal neuroimaging of frontal white matter microstructure in early phase schizophrenia: the impact of early adolescent cannabis use
Denise Bernier et al.
BMC PSYCHIATRY (2013)
Whole-Brain Analysis of Amyotrophic Lateral Sclerosis by Using Echo-Planar Spectroscopic Imaging
Gaurav Verma et al.
RADIOLOGY (2013)
Glutamate in Schizophrenia: A Focused Review and Meta-Analysis of H-1-MRS Studies
Anouk Marsman et al.
SCHIZOPHRENIA BULLETIN (2013)
Brain Volumes in Schizophrenia: A Meta-Analysis in Over 18 000 Subjects
Sander V. Haijma et al.
SCHIZOPHRENIA BULLETIN (2013)
Increased Hippocampal Glutamate and Volumetric Deficits in Unmedicated Patients With Schizophrenia
Nina V. Kraguljac et al.
JAMA PSYCHIATRY (2013)
Glutamate Levels in the Associative Striatum Before and After 4 Weeks of Antipsychotic Treatment in First-Episode Psychosis A Longitudinal Proton Magnetic Resonance Spectroscopy Study
Camilo de la Fuente-Sandoval et al.
JAMA PSYCHIATRY (2013)
Glutamatergic changes in the cerebral white matter associated with schizophrenic exacerbation
M. Ota et al.
ACTA PSYCHIATRICA SCANDINAVICA (2012)
Elevated Prefrontal Cortex γ-Aminobutyric Acid and Glutamate-Glutamine Levels in Schizophrenia Measured In Vivo With Proton Magnetic Resonance Spectroscopy
Lawrence S. Kegeles et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Regional Decoupling of N-acetyl-aspartate and Glutamate in Schizophrenia
Nina V. Kraguljac et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Anterior Cingulate Glutamate Levels Related to Clinical Status Following Treatment in First-Episode Schizophrenia
Alice Egerton et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Neurometabolites in schizophrenia and bipolar disorder - A systematic review and meta-analysis
Nina Vanessa Kraguljac et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2012)
Glutamate as a Marker of Cognitive Function in Schizophrenia: A Proton Spectroscopic Imaging Study at 4 Tesla
Juan R. Bustillo et al.
BIOLOGICAL PSYCHIATRY (2011)
Are There Progressive Brain Changes in Schizophrenia? A Meta-Analysis of Structural Magnetic Resonance Imaging Studies
Bayanne Olabi et al.
BIOLOGICAL PSYCHIATRY (2011)
Grey matter and social functioning correlates of glutamatergic metabolite loss in schizophrenia
Naoko Aoyama et al.
BRITISH JOURNAL OF PSYCHIATRY (2011)
Advances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide family
Joseph H. Neale et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Test-Retest Reliability and Reproducibility of Short-Echo-Time Spectroscopic Imaging of Human Brain at 3T
Charles Gasparovic et al.
MAGNETIC RESONANCE IN MEDICINE (2011)
Higher Levels of Glutamate in the Associative-Striatum of Subjects with Prodromal Symptoms of Schizophrenia and Patients with First-Episode Psychosis
Camilo de la Fuente-Sandoval et al.
NEUROPSYCHOPHARMACOLOGY (2011)
International Consensus Study of Antipsychotic Dosing
David M. Gardner et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Proton MRS in twin pairs discordant for schizophrenia
E. S. Lutkenhoff et al.
MOLECULAR PSYCHIATRY (2010)
1H-MRS at 4 Tesla in minimally treated early schizophrenia
J. R. Bustillo et al.
MOLECULAR PSYCHIATRY (2010)
Specific metabolites in the medial prefrontal cortex are associated with the neurocognitive deficits in schizophrenia: A preliminary study
Yukihiko Shirayama et al.
NEUROIMAGE (2010)
Glutamate Dysfunction in People with Prodromal Symptoms of Psychosis: Relationship to Gray Matter Volume
James M. Stone et al.
BIOLOGICAL PSYCHIATRY (2009)
Mapping of Brain Metabolite Distributions by Volumetric Proton MR Spectroscopic Imaging (MRSI)
A. A. Maudsley et al.
MAGNETIC RESONANCE IN MEDICINE (2009)
Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS)
Shin'Ya Tayoshi et al.
SCHIZOPHRENIA RESEARCH (2009)
Heritability of Changes in Brain Volume Over Time in Twin Pairs Discordant for Schizophrenia
Rachel G. H. Brans et al.
ARCHIVES OF GENERAL PSYCHIATRY (2008)
Abnormal Glutamatergic Neurotransmission and Neuronal-Glial Interactions in Acute Mania
Dost Oenguer et al.
BIOLOGICAL PSYCHIATRY (2008)
Comparative reliability of proton spectroscopy techniques designed to improve detection of J-coupled metabolites
Paul Gerald Mullins et al.
MAGNETIC RESONANCE IN MEDICINE (2008)
Spectroscopic metabolomic abnormalities in the thalamus related to auditory hallucinations in patients with schizophrenia
B. Martinez-Granados et al.
SCHIZOPHRENIA RESEARCH (2008)
Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia
Jean Theberge et al.
BRITISH JOURNAL OF PSYCHIATRY (2007)
Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
Sandeep T. Patil et al.
NATURE MEDICINE (2007)
Subchronic phencyclidine treatment decreases the number of dendritic spine synapses in the rat prefrontal cortex
Tibor Hajszan et al.
BIOLOGICAL PSYCHIATRY (2006)
Single-voxel 1H PRESS at 4.0T:: precision and variability of measurements in anterior cingulate and hippocampus
Talaignair N. Venkatraman et al.
NMR IN BIOMEDICINE (2006)
Use of tissue water as a concentration reference for proton spectroscopic imaging
Charles Gasparovic et al.
MAGNETIC RESONANCE IN MEDICINE (2006)
Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with review and meta-analysis
RG Steen et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study
P Ohrmann et al.
SCHIZOPHRENIA RESEARCH (2005)
A summary of the FDA-NIMH-MATRICS Workshop on Clinical Trial Design for Neurocognitive Drugs for Schizophrenia.
RW Buchanan et al.
SCHIZOPHRENIA BULLETIN (2005)
Move over ANOVA - Progress in analyzing repeated-measures data and its reflection in papers published in the archives of general psychiatry
R Gueorguieva et al.
ARCHIVES OF GENERAL PSYCHIATRY (2004)
Issues of spectral quality in clinical 1H-magnetic resonance spectroscopy and a gallery of artifacts
R Kreis
NMR IN BIOMEDICINE (2004)
Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers
J Théberge et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Automatic quantitation of localized in vivo 1H spectra with LCModel
SW Provencher
NMR IN BIOMEDICINE (2001)
Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia
LA Glantz et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the right stuff?
MF Green et al.
SCHIZOPHRENIA BULLETIN (2000)
Share Paper
